Drug library screening identifies histone deacetylase inhibition as a novel therapeutic strategy for choriocarcinoma-Reference-Cited by-同舟云学术

Drug library screening identifies histone deacetylase inhibition as a novel therapeutic strategy for choriocarcinoma

Published:2022-09-15 Issue:4 Volume:12 Page:4543-4556
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Watanabe Eri¹,Yokoi Akira¹²^ORCID,Yoshida Kosuke¹²^ORCID,Sugiyama Mai³,Kitagawa Masami³,Nishino Kimihiro¹,Yamamoto Eiko⁴,Niimi Kaoru¹,Yamamoto Yusuke⁵^ORCID,Kajiyama Hiroaki¹

Affiliation:

1. Department of Obstetrics and Gynecology Nagoya University Graduate School of Medicine Nagoya Japan

2. Institute for Advanced Research Nagoya University Nagoya Japan

3. Bell Research Center, Department of Obstetrics and Gynecology Collaborative Research Nagoya University Graduate School of Medicine Nagoya Japan

4. Department of Healthcare Administration Nagoya University Graduate School of Medicine Nagoya Japan

5. Laboratory of Integrative Oncology National Cancer Center Research Institute Tokyo Japan

Funder

Aichi Cancer Research Foundation

Japan Agency for Medical Research and Development

Japan Science and Technology Agency

Japan Society for the Promotion of Science

Princess Takamatsu Cancer Research Fund

Fusion Oriented REsearch for disruptive Science and Technology

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5243

Reference51 articles.

1. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole

2. Molar Pregnancy

3. Gestational trophoblastic disease

4. Trophoblastic disease

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment and characterization of a non-gestational choriocarcinoma patient-derived xenograft model;BMC Cancer;2023-11-13

2. Targeting Nrf2 for ferroptosis-based therapy: Implications for overcoming ferroptosis evasion and therapy resistance in cancer;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2023-10

3. Design, Synthesis, and Biological Evaluation of Novel Quinazolin-4(3H)-one-Based Histone Deacetylase 6 (HDAC6) Inhibitors for Anticancer Activity;International Journal of Molecular Sciences;2023-07-03